Showing results (111-120 of 244) with videos related to

Sort By:
Pageof 25
Seminars in Oncology|December 1, 1992
Combination chemotherapy with oral etoposideD H Johnson, J D Hainsworth, K R Hande, et al.
Obstetrics and Gynecology|September 1, 1980
Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumorC G Julian, J M Barrett, R L Richardson, et al.
AJR. American Journal of Roentgenology|January 1, 1983
Limited value of CT brain scans in the staging of small cell lung cancerD H Johnson, W W Windham, J H Allen, et al.
The American Journal of Medicine|September 1, 1986
Metastatic breast cancer confined to the skeletal system. An indolent diseaseM M Sherry, F A Greco, D H Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancerF A Greco, S L Stroup, J R Gray, et al.
American Journal of Clinical Oncology|August 1, 1989
Chemotherapy of advanced non-small-cell lung cancer: a randomized trial of three cis-platin-based chemotherapy regimensJ D Hainsworth, D H Johnson, K R Hande, et al.
Gynecologic Oncology|November 1, 1986
Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapyW W Grosh, H W Jones, L S Burnett, et al.
The American Journal of Medicine|August 1, 1983
Neoplastic meningitis. Marked variations of cerebrospinal fluid composition in the absence of extradural blockJ J Murray, F A Greco, S N Wolff, et al.
Seminars in Oncology|August 1, 1997
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancerR Birch, C H Weaver, J D Hainsworth, et al.
Cancer|February 15, 1997
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trialJ D Hainsworth, J Jolivet, R Birch, et al.
Pageof 25